Analytical Method Development and Validation – A CDMO Perspective
Pharmaceutical drug product development can be an expensive and time-consuming process. Many challenges are faced by pharmaceutical development companies including developing a scaleable, marketable formulation, ensuring safety and efficacy of the drug product and receiving approval of the drug product by regulatory agencies.
A contract development and manufacturing organization (CDMO) that understands customer needs, regulatory requirements, and has a proven track record for developing and validating analytical methods can minimize developmental costs and reduce the time to market.
Download this free white paper to find out more.
Download to find out more.